Top Markets
#1 QuantixAI QuantixAI +102.23%
#2 龙虾 (Lobster) 龙虾 (Lobster) +29.81%
#3 MetaDAO MetaDAO +26.72%
#4 Pons Pons +25.79%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +25.77%
#6 Rain Rain +25.75%
#7 Bedrock Bedrock +20.69%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +19.32%
#9 Prom Prom +18.01%
#10 Ontology Gas Ontology Gas +17.84%
Coin of the day
QuantixAI QuantixAI
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Pozycja w akcjach #2340
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Cena akcji
$43.42
Kapitalizacja rynkowa
$8.96B
Zmiana (1 dzień)
0.23%
Zmiana (1 rok)
191.61%
Kraj
US
Handel Immunovant, Inc. (IMVT)

Kategoria

Healthcare
Historia ceny akcji dla Immunovant, Inc. (IMVT)
Najwyższa cena zamknięcia: $42.51 dnia 2026-08-01

Najniższa cena zamknięcia: $9.88 dnia 2019-06-01
Historia cen akcji firmy Immunovant, Inc. od 2019 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.23 42.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.35%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $157.70 522.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH